oxazolidin-2-one has been researched along with Pulmonary Aspergillosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acquarolo, A; Carori, G; Fiorese, B; Magri, S; Pantosti, A; Signorini, L; Soavi, L; Stellini, R; Suter, F | 1 |
1 other study(ies) available for oxazolidin-2-one and Pulmonary Aspergillosis
Article | Year |
---|---|
Linezolid and clindamycin improve the outcome of severe, necrotizing pneumonia due to community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).
Topics: Acetamides; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Clindamycin; Combined Modality Therapy; Community-Acquired Infections; Drug Therapy, Combination; Echinocandins; Female; Hemofiltration; Humans; Hydrocortisone; Linezolid; Lipopeptides; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Necrosis; Oxazolidinones; Oxygen Inhalation Therapy; Pneumonia, Bacterial; Pulmonary Aspergillosis; Respiration, Artificial; Shock, Septic; Staphylococcal Infections | 2011 |